Disputes

Proactive Protection

Insights

About

Contact

Disputes

Case Validation
AI intelligence to assess case strength and likely outcome.

Damages prediction
Quantify potential damages with evidence backed estimates.

Litigation Funding
Non recourse capital to pursue strong trade secret claims.

Enforce your rights
When theft occurs, Tangibly delivers the proof, funding, and expertise to recover what is yours.

Insights

Reasonable Measures Podcast
Expert conversations on trade secrets, IP strategy, and the disputes shaping modern innovation.

Customer Stories
How companies use Tangibly to protect critical know how and pursue enforcement.

Sign up for The Tangibly Brief
Expert insights on trade secret protection and enforcement, delivered to your inbox.

About

Company
About Tangibly, our leadership, and career opportunities.

Newsroom
Press, announcements, and company updates.

Sim IP x Tangibly Litigation Financing Partnership
Learn more about how Tangibly and SIM IP are making trade secret enforcement more accessible for innovators.

Jazz Pharmaceuticals, Inc. v. Synchrony Group, LLC, et al.

by Tangibly | Jun 13, 2024 | Case Law & Industry Trends, Case Law Reviews, Medical

In this 2018 case, Jazz Pharmaceuticals, Inc. sued Synchrony
Group, LLC, and its related entities for violations of the DTSA,
PUTSA, breach of contract, breach of duty of loyalty, and breach
of fiduciary duty. The dispute emerged after Synchrony,
contracted under a Master Services Agreement to provide
marketing support for Jazz, expressed interest in working with
Jazz’s competitor, Harmony, and terminated its relationship
with Jazz. Jazz alleged that Synchrony misappropriated trade
secrets and breached their contract. The court granted
Synchrony’s motion to dismiss in part, specifically the claims for
breach of duty of loyalty and breach of fiduciary duty, under the
gist of the action doctrine but allowed the claims for
misappropriation of trade secrets and breach of contract to
proceed. This case highlights the critical role of contractual
agreements in safeguarding trade secrets and the legal
boundaries of corporate relationships and obligations in the
pharmaceutical industry.

Last Updated:May, 2026

Table Of Content

Sign up for The Tangibly Brief

Expert insights on trade secret protection and enforcement, delivered to your inbox.